Soluble CTLA4 mutant molecules and uses thereof
US7105166B1 · kind B1 · utility
21Cited by
16References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2000 |
| Grant date | Sep 12, 2006 |
| Priority date | — |
| Expiry date | Apr 10, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides soluble CTLA4 mutant molecules which bind CD80 and/or CD86 antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.